Based on this evidence, multidisciplinary guidelines have listed GLP 1RAs as first - line or preferred treatment options for patients with type 2 diabetes and/or obesity with high cardiovascular risk [51, 52]
Specifically, patients reported experiencing stomachache (4 participants), nausea (2 participants), burping (2 participants) and flatulence (3 participants) (Table 3)
Start with the basics that matter most
With 2,300 participants, TRIUMPH-1 has the scale to detect relatively rare safety signals that smaller trials might miss
They are not generic equivalents of Ozempic , Wegovy , Mounjaro , or Zepbound
Some of the most common benefits of peptide therapy include: Improved immune function: Peptides can stimulate the immune system, which can help to fight off infections and reduce the risk of chronic diseases